
Most HR leaders know alternative funding is worth exploring. Fewer know where to start. If you've been curious about how arrangements like level funding, gap funding, or self-funding actually work, what they mean for your employees, or how to bring the conversation to your finance team, this is the session for you.
We'll break down the basics of alternative funding, including funding types, how they differ from fully insured, what the transition looks like, and why claims data access is one of the most underrated advantages of making the switch.
Bring your questions. No slides, no filler. Just honest answers from people who work through this with employers every day.
Ask anything, including:
Walk away with a clearer picture of what alternative funding types could unlock for your organization, and the confidence to take the next step.

With over 20 years in the employee benefits space, Rachel brings deep expertise in funding strategies, cost management, and navigating complex benefits challenges across both public and private sectors. As a Partner at Nava, she's passionate about helping organizations build thoughtful, high-impact benefits programs that truly support their people. Rachel has a particular focus on self-funding and alternative funding strategies, helping HR leaders cut through the complexity and make confident decisions about how their benefits are structured.
Outside of work, she enjoys walks, audiobooks, and spending time with her 6-year-old daughter and close-knit family.

Nick Moores is a Senior Benefits Advisory at Nava Benefits with 10 years of experience partnering with People Operations teams on benefits strategy and talent acquisition. He specializes in building healthcare solutions that work for employees and the bottom line, helping HR leaders turn benefits from a cost center into a competitive advantage. Before joining Nava, Nick advised HR and recruiting teams at Greenhouse and recruited top talent at Barrington James across competitive industries. In a previous life, he was a research scientist working on genetic engineering of viral vectors to treat brain cancer.
